1. Women's perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia.
- Author
-
Heimberger, Sarah, Perdigao, Joana Lopes, Mueller, Ariel, Arenas, Gabriel, Kuriloff, Melissa, Duncan, Colleen, Amegashie, Courtney, and Rana, Sarosh
- Abstract
Objective: This study aimed to evaluate womens' perspectives about current and novel preeclampsia testing methods at an urban tertiary medical center.Methods: This was an observational survey study conducted between October 1, 2020 and December 31, 2020. Subjects were eligible if they were ≥ 18 years of age and had a diagnosis of gestational hypertension, preeclampsia, or superimposed preeclampsia at the time of delivery. Informed consent was obtained, and the 26-question survey was administered after delivery. A detailed medical record review was completed for respondents (patients) and their neonates.Results: A total of 100 women were included in the study. The majority of participants were Black (78%) and/or on Medicaid (51%). Most respondents agreed that they fully trust their doctor and medical team (96%) and that the newest medical tests, treatments, and technologies should always be used (91%). Most women (80%) at least somewhat agreed they have enough knowledge about preeclampsia and its complications. Over 90% of women agreed a test to predict complications of preeclampsia would be useful to them. Most women reported a rule out test would be useful to them because it would help them worry less (68%), reduce hospitalizations (32%) and reduce interventions (17%).Conclusion: There was majority support for novel methods such as biomarker testing among this cohort. Most patients reported the test would decrease worry associated with preeclampsia development and complications. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF